PORTAL VERSUS PERIPHERAL CIRCULATING TUMOR CELLS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH STAGE I-III PANCREATIC DUCTAL ADENOCARCINOMA

被引:0
|
作者
Prasoppokakorn, Thaninee
Chaiteerakij, Roongruedee
Buntho, Areeya
Ingrungruanglert, Praewphan
Israsena, Nipan
Ridtitid, Wiriyaporn
Angsuwatcharakon, Phonthep
Mekaroonkamol, Parit
Kongkam, Pradermchai
Rerknimitr, Rungsun
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
359
引用
收藏
页码:S63 / S64
页数:2
相关论文
共 50 条
  • [41] Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma Mini-Review
    Liberko, Marian
    Kolostova, Katarina
    Szabo, Arpad
    Gurlich, Robert
    Oliverius, Martin
    Soumarova, Renata
    IN VIVO, 2021, 35 (01): : 31 - 39
  • [42] Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy
    Chatterjee, Deyali
    Katz, Matthew H.
    Foo, Wai Chin
    Sundar, Manonmani
    Wang, Hua
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Lee, Jeffrey E.
    Maitra, Anirban
    Fleming, Jason B.
    Rashid, Asif
    Wang, Huamin
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (08) : 1097 - 1104
  • [43] Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma
    Michael G. White
    Andrew Lee
    Diego Vicente
    Carolyn Hall
    Michael P. Kim
    Matthew H. G. Katz
    Jeffrey E. Lee
    Naruhiko Ikoma
    Anthony Lucci
    Ching-Wei D. Tzeng
    Annals of Surgical Oncology, 2021, 28 : 4615 - 4622
  • [44] Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients
    Hall, Carolyn
    Krishnamurthy, Savitri
    Lodhi, Ashutosh
    Mosalpuria, Kailash
    Kuerer, Henry M.
    Meric-Bernstam, Funda
    Bedrosian, Isabelle
    Hunt, Kelly K.
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) : 3252 - 3258
  • [45] Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma
    White, Michael G.
    Lee, Andrew
    Vicente, Diego
    Hall, Carolyn
    Kim, Michael P.
    Katz, Matthew H. G.
    Lee, Jeffrey E.
    Ikoma, Naruhiko
    Lucci, Anthony
    Tzeng, Ching-Wei D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4615 - 4622
  • [46] An Exploratory Study of Inflammatory Cytokines as Prognostic Biomarkers in Patients With Ductal Pancreatic Adenocarcinoma
    Dima, Simona O.
    Tanase, Cristiana
    Albulescu, Radu
    Herlea, Vlad
    Chivu-Economescu, Mihaela
    Purnichescu-Purtan, Raluca
    Dumitrascu, Traian
    Duda, Dan G.
    Popescu, Irinel
    PANCREAS, 2012, 41 (07) : 1001 - 1007
  • [47] Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
    Chou, Cheng-Wei
    Hsieh, Yu-Hsiu
    Ku, Su-Chi
    Shen, Wan-Jou
    Anuraga, Gangga
    Khoa Ta, Hoang Dang
    Lee, Kuen-Haur
    Lee, Yu-Cheng
    Lin, Cheng-Hsien
    Wang, Chih-Yang
    Wang, Wei-Jan
    BIOMEDICINES, 2021, 9 (11)
  • [48] Tumor infiltrating T cells influence prognosis in stage I-III NSCLC patients
    Schulze, A. B.
    Evers, G.
    Goerlich, D.
    Mohr, M.
    Marra, A.
    Hillejan, L.
    Rehkaemper, J.
    Heitkoetter, B.
    Schmidt, L. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 138 - 138
  • [49] Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
    Gall, Tamara M. H.
    Belete, Samuel
    Khanderia, Esha
    Frampton, Adam E.
    Jiao, Long R.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (01): : 71 - 81
  • [50] Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
    Gu, J.
    Lei, F.
    Wang, X.
    Huang, W.
    He, X.
    Hong, Y.
    Zeng, Q.
    Wang, Y.
    Gao, Q.
    Niu, P.
    Huang, D.
    Gao, Z.
    Ding, C.
    Zhai, Z.
    An, K.
    Chen, H.
    Zhao, X.
    Chen, S.
    Bai, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S561 - S561